Axa S.A. Molecular Templates, Inc. Transaction History

Axa S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $118,490 - $161,130	-20,500 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$7.82 - $12.44 $532,542 - $847,164	-68,100 Reduced 76.86%	20,500 $160,000
Q1 2021 May 14, 2021	BUY	$9.33 - $14.05 $826,638 - $1.24 Million	88,600 New	88,600 $1.12 Million
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $2.98 Million - $4.82 Million	-263,840 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$6.44 - $14.21 $2.59 Million - $5.71 Million	-401,641 Reduced 60.35%	263,840 $3.69 Million

Q3 2019 Nov 14, 2019	BUY	$4.6 - $8.46 $239,232 - $439,979	52,007 Added 8.48%	665,481 $4.39 Million
Q2 2019 Aug 13, 2019	BUY	$5.83 - $8.42 $78,553 - $113,451	13,474 Added 2.25%	613,474 $5.12 Million
Q3 2018 Nov 08, 2018	BUY	$4.07 - $6.25 $2.44 Million - $3.75 Million	600,000 New	600,000 $3.23 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $65.4M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.